Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1993 Mar;36(2):123–126. doi: 10.1007/BF01754412

Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells

Andrea Ladányi 1,, József Tímár 1, Károly Lapis 1
PMCID: PMC11038637  PMID: 8425209

Abstract

We studied the effect of lentinan, a fungal polysaccharide immunomodulator, on mouse peritoneal macrophages. The i.p. treatment of mice with 10 mg/kg lentinan affected the number, plastic-adherence, and endogen peroxidase activity of peritoneal cells. The cytotoxicity of lentinan-stimulated peritoneal macrophages was determined against several murine and human metastatic tumor targets: Lewis lung carcinoma (LLT) and two human melanomas, and was found to be significantly higher than that of the macrophages from control animals. However, the highly metastatic variant of LLT (LLT-HH) was resistant to the cytolytic effect of resident and lentinan-activated macrophages as well, indicating that the stimulation for cytotoxicity depends not only on the functional activity of the effector but also on the sensitivity of the target.

Key words: Lentinan, Tumor, Cytotoxicity, Macrophages

References

  • 1.Ábel G, Szöllösi J, Chihara G, Fachet J. Effect of lentinan and mannan on phagocytosis of fluorescent latex microbeads by mouse peritoneal macrophages: a flow cytometric study. Int J Immunopharmacol. 1989;11:615–615. doi: 10.1016/0192-0561(89)90146-x. [DOI] [PubMed] [Google Scholar]
  • 2.Chihara G, Hamuro J, Maeda YY, Shiio T, Suga T, Takasuka N, Sasaki T. Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator. Cancer Detect Prev [Suppl] 1987;1:423–423. [PubMed] [Google Scholar]
  • 3.Dennis JW, Laferte S. Recognition of asparagine-linked oligosaccharides on murine tumor cells by natural killer cells. Cancer Res. 1985;45:6034–6034. [PubMed] [Google Scholar]
  • 4.Fidler IJ, Balch CM. The biology of cancer metastasis and implications for therapy. Curr Probl Surg. 1987;24:137–137. doi: 10.1016/0011-3840(87)90002-5. [DOI] [PubMed] [Google Scholar]
  • 5.Fruehauf JP, Bonnard GD, Herberman RB. The effect of lentinan on production of interleukin-1 by human monocytes. Immunopharmacology. 1982;5:65–65. doi: 10.1016/0162-3109(82)90037-6. [DOI] [PubMed] [Google Scholar]
  • 6.Gergely P, Vallent K, Bodó I, Fehér J, Kaneko Y. Effects of lentinan on cytotoxic functions of human lymphocytes. Immunopharmacol Immunotoxicol. 1988;10:157–157. doi: 10.3109/08923978809014330. [DOI] [PubMed] [Google Scholar]
  • 7.Hamuro J, Röllinghoff M, Wagner H. Induction of cytotoxic peritoneal exudate cells by T-cell immune adjuvants of the β (1–3)glucan-type lentinan and its analogues. Immunology. 1980;39:551–551. [PMC free article] [PubMed] [Google Scholar]
  • 8.Herlyn D, Kaneko Y, Rowe J, Aoki T, Koprowski H. Monoclonal antibody-dependent murine macrophage-mediated cytotoxicity against human tumors is stimulated by lentinan. Gann. 1985;76:37–37. [PubMed] [Google Scholar]
  • 9.Lapis K, Pál K, Kopper L, Tímár J, Jeney A, Paku S, Pápay J. Chemotherapy of experimental metastasis. In: Saccani F, Becchi G, Carretti D, Maltoni C, editors. Le metastasi. Bologna: Monduzzi; 1986. pp. 13–13. [Google Scholar]
  • 10.Lapis K, Tímár J, Pál K, Jeney A, Timár F, Kopper L. Membrane properties of Lewis lung tumor cells with low and high metastatic capacity. Antimetastatic effect of a glycosaminoglycan biosynthesis blocking agent 5-hexyl-2′-deoxyuridine (HUdR) In: Cory JG, Szentivanyi A, editors. Cancer biology and therapeutics. New York: Plenum; 1987. pp. 79–79. [Google Scholar]
  • 11.Lapis K, Pápay J, Paku S, Szende B. The effect of lentinan on the metastasis of Lewis lung carcinoma. Int J Immunother. 1989;5:195–195. [Google Scholar]
  • 12.Lapis K, Tímár J, Pápay J, Paku S, Szende B, Ladányi A. Experimental metastasis inhibition by the pretreatment of the host. Arch Geschwulstforsch. 1990;60:97–97. [PubMed] [Google Scholar]
  • 13.Nanba H, Kuroda K. Antitumor mechanisms of orally administered shiitake fruit bodies. Chem Pharm Bull (Tokyo) 1987;35:2459–2459. doi: 10.1248/cpb.35.2459. [DOI] [PubMed] [Google Scholar]
  • 14.Nanba H, Mori K, Toyomasu T, Kuroda H. Antitumor action of shiitake (Lentinus edodes) fruit bodies orally administered to mice. Chem Pharm Bull (Tokyo) 1987;35:2453–2453. doi: 10.1248/cpb.35.2453. [DOI] [PubMed] [Google Scholar]
  • 15.Nicolson GL. Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim Biophys Acta. 1988;948:175–175. doi: 10.1016/0304-419x(88)90010-8. [DOI] [PubMed] [Google Scholar]
  • 16.Pál K, Kopper L., Lapis K. Increased metastatic capacity of Lewis lung tumor cells by in vivo selection procedure. Invasion Metastasis. 1983;3:174–174. [PubMed] [Google Scholar]
  • 17.Pál K, Kopper L., Tímár J, Rajnay J, Lapis K. Comparative study on Lewis lung tumor lines with “low” and “high” metastatic capacity: I. Growth rate, morphology and tumor-host relation. Invasion Metastasis. 1985;5:159–159. [PubMed] [Google Scholar]
  • 18.Rosenberg SA, Lotze MT. Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes. Annu Rev Immunol. 1986;4:681–681. doi: 10.1146/annurev.iy.04.040186.003341. [DOI] [PubMed] [Google Scholar]
  • 19.Stötter H, Lotze MT. Cytolytic effector cells against human tumors: distinguishing phenotype and function. Cancer Cells. 1990;2:44–44. [PubMed] [Google Scholar]
  • 20.Taguchi T, Kaneko Y. Lentinan: an overview of experimental and clinical studies of its action against cancer. In: Urushizaki I, Aoki T, Tsubura E, editors. Host defense mechanisms against cancer. Amsterdam: Excerpta Medica; 1986. pp. 221–221. [Google Scholar]
  • 21.Tímár J, Moczar E, Timár F, Pál K, Kopper L, Lapis K, Jeney A. Comparative study on Lewis lung tumor lines with “low” and “high” metastatic capacity: II. Cytochemical and biochemical evidence for differences in glycosaminoglycans. Clin Exp Metastasis. 1987;5:79–79. doi: 10.1007/BF00116628. [DOI] [PubMed] [Google Scholar]
  • 22.Tímár J, Kovalszky I, Paku S, Lapis K, Kopper L. Two human melanoma xenografts with different metastatic capacity and glycosaminoglycan pattern. J Cancer Res Clin Oncol. 1989;115:554–554. doi: 10.1007/BF00391357. [DOI] [PubMed] [Google Scholar]
  • 23.Tímár J, Ladányi A, Lapis K, Moczar E. Galactosylated glycan expression and macrophage sensitivity of Lewis lung tumor cells with different metastatic phenotype. J Cancer Res Clin Oncol. 1990;116:264–264. doi: 10.1007/BF01612901. [DOI] [PubMed] [Google Scholar]
  • 24.Whitworth PW, Pak CC, Esgro J, Kleinerman ES, Fidler IJ. Macrophages and cancer. Cancer Metastasis Rev. 1990;8:319–319. doi: 10.1007/BF00052607. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES